Register Login
Register to leave comments
  • News bot Aug. 11, 2026, 8:12 p.m.

    🔍 Struthers Richard Scott (Director)

    Company: Crinetics Pharmaceuticals, Inc. (CRNX)

    Report Date: 2026-08-07

    Transaction Summary:

    • Total transactions: 18
    • Derivative instruments: 4
    • Holdings reported: 10
    • Total shares acquired: 19,928
    • Total shares sold: 19,928
    • Total shares held: 978,205

    Detailed Transactions and Holdings:

    • Acquired 3,969 shares of Common Stock at $25.19 per share (Direct)
      Date: 2026-08-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 408,747.00 | transaction_form_type: 4
    • Acquired 4,422 shares of Common Stock at $22.61 per share (Direct)
      Date: 2026-08-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 413,169.00 | transaction_form_type: 4
    • Acquired 6,542 shares of Common Stock at $15.29 per share (Direct)
      Date: 2026-08-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 419,711.00 | transaction_form_type: 4
    • Acquired 4,995 shares of Common Stock at $20.02 per share (Direct)
      Date: 2026-08-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 424,706.00 | transaction_form_type: 4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-07 | Code: H | nature_of_ownership: By Family Trust 1 | shares_owned_after: 136,805.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-07 | Code: H | nature_of_ownership: By Family Trust 2 | shares_owned_after: 106,000.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-07 | Code: H | nature_of_ownership: By Family Trust 3 | shares_owned_after: 110,000.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-07 | Code: H | nature_of_ownership: By Family Trust 4 | shares_owned_after: 100,000.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-07 | Code: H | nature_of_ownership: By Family Trust 5 | shares_owned_after: 111,100.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-07 | Code: H | nature_of_ownership: By Family Trust 6 | shares_owned_after: 111,100.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-07 | Code: H | nature_of_ownership: By Family Trust 7 | shares_owned_after: 111,100.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-07 | Code: H | nature_of_ownership: By Family Trust 8 | shares_owned_after: 111,100.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-07 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 1,000.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-07 | Code: H | nature_of_ownership: By Charitable Trust | shares_owned_after: 80,000.00
    • Sold 3,969 shares of Stock Option (Right to Buy) at $25.19 per share (Derivative)
      Date: 2026-08-07 | Code: M | Expires: 2029-03-08 | equity_swap_involved: 0 | shares_owned_after: 172,281.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 4,422 shares of Stock Option (Right to Buy) at $22.61 per share (Derivative)
      Date: 2026-08-07 | Code: M | Expires: 2030-02-24 | equity_swap_involved: 0 | shares_owned_after: 195,578.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 6,542 shares of Stock Option (Right to Buy) at $15.29 per share (Derivative)
      Date: 2026-08-07 | Code: M | Expires: 2031-02-26 | equity_swap_involved: 0 | shares_owned_after: 259,058.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 4,995 shares of Stock Option (Right to Buy) at $20.02 per share (Derivative)
      Date: 2026-08-07 | Code: M | Expires: 2032-02-29 | equity_swap_involved: 0 | shares_owned_after: 244,205.00 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: 1/48th of the shares subject to the option vested monthly.
    • F2: 1/48th of the shares subject to the option vested on March 24, 2020, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
    • F3: 1/48th of the shares subject to the option vested on March 26, 2021, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
    • F4: 1/48th of the shares subject to the option vested on March 31, 2022, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Search

News categories